Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

refractory hematologic cancer - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

refractory hematologic cancer

MONDO:0004111

Also known as:refractory hematologic malignancy

Find Clinical TrialsTrials

Overview

A hematologic malignancy that is resistant to treatment.

Clinical Trials3 registered · 2 recruiting

ResearchLimited published research (9 articles)

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

3 clinical trials registered, 2 recruiting. Interventions under study include other interventions and drug therapy. Pipeline includes 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.

9 publications have been identified in PubMed for refractory hematologic cancer. Research spans Basic Science / Preclinical (44%), Review / Meta-Analysis (33%), and Clinical Trial Publication (22%).

Recent Publications

Ababneh HS (2026). [PMID: 41580148](https://pubmed.ncbi.nlm.nih.gov/41580148/). *Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology*. [Clinical Trial Publication]
Suzuki K (2026). [PMID: 41239848](https://pubmed.ncbi.nlm.nih.gov/41239848/). *Cancer science*. [Basic Science / Preclinical]
Yokoyama H (2026). [PMID: 41056522](https://pubmed.ncbi.nlm.nih.gov/41056522/). *Blood advances*. [Clinical Trial Publication]
Tian Y (2025). [PMID: 41231037](https://pubmed.ncbi.nlm.nih.gov/41231037/). *Cancer medicine*. [Review / Meta-Analysis]

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 10:41 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 3 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

refractory hematologic cancer

Overview

Research Landscape

Recent Publications

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team